Pre-treatment of striatal slices by DCF decreases HDA uptake (a) and dopamine content (b) by Elisaveta Milusheva (45672)

Decreased CSF cytokine levels in α7 KO mice. by Feng Chi (170688)

HDAC inhibition by TSA decreases SREBP2 proteolytic cleavage. by Maria João Nunes (160499)

AR1’s occurrence gives rise to a decreased preference of ABP for AR2 and 3. by Li-Dong Huang (5659273)

Nicotine decreases PDI expression in e15 rat placentas. by Michael K. Wong (646399)

Cilostazol decreases OC formation and bone resorption induced by RANKL. by Ke Ke (583325)

Silencing of RCC1L isoforms alter the levels of mitochondrial ribosomal proteins and biogenesis factors resulting in decreased mitochondrial translation. by Aurelio Reyes (412135)

Expression of human PON1 decreases superoxide levels in <i>D. melanogaster</i>. by Alejandro A. Pezzulo (138238)

Activation of NMDA receptors with D-serine obviously limited the decrease of p-CREB in the hippocampus of the surviving LPS-treated mice. by Shuibing Zhang (4336402)

The protein level of ApoB was decreased in HCV-infected cells. by Bei Wang (116772)

Excel data file with all collected data. by Marcus Persson (20496333)

“…During the five-day treatment period and at a follow-up visit after 30 days we closely monitored adverse events and collected self-rated side effect data. …”

<i>mbtK</i> deletion decreases phospholipid abundance during iron starvation. by Cressida A. Madigan (713924)

AnxA5 results in a tendency to decrease the monocyte endothelium interaction in a flow model. by Robert Stöhr (3583700)

Procedure for decreasing the required time for fire resistance of the multistory buildings by V. P. SILVA (4642840)

A savanna response to precipitation intensity - Fig 5 by Ryan S. Berry (3913207)

Anandamide decreases locomotor activity and rearing in small open field. by Adriaan W. Bruijnzeel (2605954)

GSK-3β inhibition or silencing decreases reporter activity. by Rong Guo (50063)

SPARC overexpression promotes AC invasion by decreasing type IV collagen levels in the BM. by Meghan A. Morrissey (2541352)

Structure comparison of MAP30 and Momordin. by Norman R. Watts (1964959)

Subjects:

Activation, inactivation, and deactivation kinetics differ between Ca_V3.3 WT and variants as well as among the variants. by Yousra El Ghaleb (22075892)

Subjects: